End Stage Liver DIsease, Liver Transplantation
Conditions
Keywords
endothelial, plasma
Brief summary
To study the effects of plasma transfusionon during liver transplantation on endothelial condition and short-term outcome in patients with end-stage liver disease.
Interventions
perform plasma transfusion in different phases during perioperation
get blood samples at several specific points in time during perioperation
Sponsors
Study design
Eligibility
Inclusion criteria
* Child A/B cirrhosis * patients who undergo the first OLT * Informed and consented * complete follow-up * cooperate with treatment
Exclusion criteria
* re-transplant * combined liver and other organ transplantation * BMI≥30Kg/m2 * patients with hypertension, diabetes, coronary heart disease, chronic renal insufficiency, preoperative pulmonary infection, pleural effusion * acute liver failure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| endothelial glycocalyx layer shedding markers | 24 hours | plasma concentration of endothelial glycocalyx layer shedding markers |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| inflammatory cytokines | 24 hours | levels of inflammatory cytokines |
Countries
China